Carrillo ER, Guevara AL, Carrillo CJR, Vinay RB

Language: Spanish
References: 24
Page: 68-72
PDF size: 96.82 Kb.

ABSTRACT

Objective: To evaluate vasopressor effect on the glucose levels in critically ill patients admitted to an Intensive Care Unit (ICU). Patients and methods: We evaluate the central and capillary glucose levels in 10 patients who were admitted in to the ICU, they were divided into two groups. Group 1: 5 patients without vasopressor infusion, 20 samples were taken from them, (10 central catheter and 10 capillary test). Group 2: 5 patients with vasopressor infusion which had 20 samples taken from them, (10 central catheter and 10 capillary test). In both groups same measure system was used. (Medisense Optium Xceed®). Results: 10 patients were studied, 6 men (60%) and 4 women (40%). In the vasopressor group, central glucose levels were higher, with a mean 170.12 ± 66.81, in the non-vasopressor group glucose levels were 127.36 ± 45.49, p ‹ 0.001. Capillary glucose in the vasopressor group was 167.82 ± 73.71, in non-vasopressor 128.82 ± 52.18, p ‹ 0.001. Conclusions: Vasopressor infusion significantly increases the capillary and central glucose levels in the critically ill patient.

REFERENCES

1. Laird AM, Millar PR, Kilgo PD, Meredith WJ. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma 2004; 56: 1058-1062.

2. Lange MP, Dahn MS, Jacobs LA. The significance of hyperglycemia after injury. Heart Lung 1985; 14: 470-472.

3. Capes SE, Hunt D, Malmberg K. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients. Stroke 2001; 32: 2426-2436.

4. Gore DC, Chinkes D, Heggers J. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 2001; 51: 540-543.

5. Guvener M, Pasaoglu I, Demircin M. Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetes patients after coronary artery bypass grafting. Endocrinol J 2002; 49: 531-537.

6. Van den Berghe G, Wouters PJ, Bouillon R. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003; 31: 359-366.

7. Capes SE, Hunt DM. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 335: 773-778.

8. Rovlias A, Kotsou S. The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery 1999; 46: 335-342.

9. Trager K, DeBacker D, Radermacher P. Metabolic alterations in sepsis and vasoactive drug-related metabolic effects. Curr Opin Crit Care 2003; 9: 271-278.

10. Haffner CA, Kendall MU. Metabolic effects of B2-agonists. J Clin Pharm Ther 1992; 17: 155-164.

11. Trager K, Radermacher P, DeBacker D. Metabolic effects of vasoactive agents. Curr Opin Anaesthesiol 2001; 14: 157-163.

12. Obritsch MD, Jung R, Fish DN, MacLaren R. Effects of continuous vasopressin infusion in patients with septic shock. Ann Pharmacother 2004; 38: 1117-1122.

13. Halter JB, Beard JC, Porte D. Islet function and stress hyperglycemia: plasma glucose and epinephrine interaction. Am J Physiol 1984; 247: 47-52.

14. Wolfe RR, Durkot MJ, Allsop JR. Glucose metabolism in severely burned patients. Metabolism 1979; 28: 210-220.

15. Mizock BA. Alterations in carbohydrate metabolism during stress: A review of the literature. Am J Med 1995; 98: 75-84.

16. McCowen KC, Malhorta A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin 2001; 17: 107-124.

17. Nishikawa T, Edelstein D, Du XL, Yamagishi S. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000; 404: 787-790.

18. Williams SB, Goldfine AB, Timini FK, Ting HH. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 1998; 97: 1695-1701.

19. D’Amico M, Marfella R, Nappo F, Di Filippo C, De Angelis L. High glucose induces ventricular instability and increases vasomotor tone in rats. Diabetologia 2001; 44: 464-470.

20. Losser MR, Bernard C, Beaudeux JL, Pison C, Payen D. Glucose modulates hemodynamic, metabolic and inflammatory responses to lipopolysaccharide in rabbits. J Appl Physiol 1997; 83: 1566-1574.

21. Van der Berghe G, Wouters P, Weekers F. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 1359-1367.

22. Van der Berghe G, Wouters P, Bouillon R. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003; 31: 359-366.

23. Van der Berghe G, Schoonheydt K, Becx P, Bruynincks F. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 2005; 64: 1348-1353.

24. Groeneveld J, Beishuizen A, Visser FC. Insulin: a wonder drug in the critically ill? Crit Care 2002; 6: 102-105.